Cornerstone Capital Management Holdings’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$11.6M Buy
71,164
+7,189
+11% +$1.29M 0.08% 268
2017
Q3
$13.1M Buy
63,975
+184
+0.3% +$42.8K 0.1% 232
2017
Q2
$15.5M Sell
63,791
-104
-0.2% -$24.4K 0.12% 196
2017
Q1
$15.3M Sell
63,895
-9,240
-13% -$2.15M 0.12% 205
2016
Q4
$15.4M Buy
+73,135
New +$15.2M 0.12% 198
2013
Q4
Sell
-42,459
Closed -$6.11M 1358
2013
Q3
$6.11M Sell
42,459
-16,440
-28% -$2.19M 0.07% 350
2013
Q2
$7.44M Buy
+58,899
New +$6.67M 0.09% 288

Other funds holding AGN

Cornerstone Capital Management Holdings's AGN Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Allergan plc (AGN) stake by 11% in Q4 2017, buying an estimated $1.29M and bringing the position to 71,164 shares worth $11.6M. The position accounts for 0.08% of the portfolio, ranked #268.

Cornerstone Capital Management Holdings first reported a position in AGN in Q2 2013 and has held it in 7 quarters since. The position peaked at $15.5M in Q2 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Cornerstone Capital Management Holdings held 71,164 shares of Allergan plc worth $11.6M as of Q4 2017.
  • Cornerstone Capital Management Holdings bought 7,189 Allergan plc shares in Q4 2017, an estimated $1.29M.
  • Allergan plc made up 0.08% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #268 holding.
  • Cornerstone Capital Management Holdings first reported a position in Allergan plc in Q2 2013 and has held it in 7 quarters since.
  • Cornerstone Capital Management Holdings's Allergan plc position peaked at $15.5M in Q2 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.